These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 1803510)

  • 21. Fifteen coagulation and fibrinolysis parameters in diabetes mellitus and in patients with vasculopathy.
    Christe M; Fritschi J; Lämmle B; Tran TH; Marbet GA; Berger W; Duckert F
    Thromb Haemost; 1984 Oct; 52(2):138-43. PubMed ID: 6084321
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Clinical value of the measure of global fibrinolytic activity].
    Guillaume M; Zouaoui Boudjeltia K; Cauchie P; Hénuzet C
    Rev Med Brux; 2001 Apr; 22(2):A115-7. PubMed ID: 11388033
    [No Abstract]   [Full Text] [Related]  

  • 23. A multiparameter test of clot formation and fibrinolysis for in-vitro drug screening.
    Kostka B; Para J; Sikora J
    Blood Coagul Fibrinolysis; 2007 Oct; 18(7):611-8. PubMed ID: 17890947
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Plasma fibrinolytic activity following oral anabolic steroid therapy.
    Walker ID; Davidson JF; Young P; Conkie JA
    Thromb Diath Haemorrh; 1975 Sep; 34(1):236-45. PubMed ID: 1103357
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Behavior of the euglobulin lysis time in diabetics with moderate arteriosclerosis subjected to various therapeutic treatments].
    Avellone G; Novo S; Vinci G
    Boll Soc Ital Cardiol; 1976; 21(12):2107-14. PubMed ID: 1031638
    [No Abstract]   [Full Text] [Related]  

  • 26. Fibrinogen content and fibrinolytic activity of blood in diabetics, before and after antidiabetic drugs.
    Bedi HK; Vyas BR; Bomb BS; Agarwal ML; Bedi T
    J Assoc Physicians India; 1977 Mar; 25(3):181-5. PubMed ID: 914747
    [No Abstract]   [Full Text] [Related]  

  • 27. [Changes in coagulographic indices in patients with myocardial infarction and concomitant diabetes and without diabetes during anticoagulant treatment].
    Maĭmunkov K; Tsekov M; Delibasheva A
    Vrach Delo; 1977 Jan; (1):62-5. PubMed ID: 847950
    [No Abstract]   [Full Text] [Related]  

  • 28. [Fibrinolytic response to moderate exercise and platelet adhesiveness in diabetes mellitus].
    Seth HN
    Acta Diabetol Lat; 1973; 10(2):306-314. PubMed ID: 4741835
    [No Abstract]   [Full Text] [Related]  

  • 29. The effects of phenphormin on blood fibrinolysis in diabetes mellitus.
    Fiaschi E; Barbui T; Previato G; Di Luzio V; Guarnieri GF; Todesco S
    Arzneimittelforschung; 1969 Apr; 19(4):638-40. PubMed ID: 5819165
    [No Abstract]   [Full Text] [Related]  

  • 30. The prognostic value of pre-discharge exercise testing after myocardial infarction treated with either primary PCI or fibrinolysis: a DANAMI-2 sub-study.
    Valeur N; Clemmensen P; Saunamäki K; Grande P;
    Eur Heart J; 2005 Jan; 26(2):119-27. PubMed ID: 15618067
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Blood clotting and fibrinolytic activity in patients with adult-onset diabetes].
    Józef K; Zbigniew K; Maria K; Barbara KG; Dorota P
    Pol Tyg Lek; 1973 Aug; 28(32):1217-9. PubMed ID: 4750053
    [No Abstract]   [Full Text] [Related]  

  • 32. [Therapeutic strategies to improve the outcome of patients with diabetes mellitus and acute coronary syndrome].
    Cavallini C
    G Ital Cardiol (Rome); 2006 Apr; 7(4 Suppl 1):13S-20S. PubMed ID: 16749287
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Fibrinolytic therapy in myocardial infarct].
    Steingass G
    Prensa Med Argent; 1967 Mar; 54(3):98-105. PubMed ID: 5614749
    [No Abstract]   [Full Text] [Related]  

  • 34. Fibrinolysis and coagulation. Effect of calcium and of coagulation on the lysis of fibrin clots.
    Helle I
    Scand J Haematol Suppl; 1968; 4():1-46. PubMed ID: 4181525
    [No Abstract]   [Full Text] [Related]  

  • 35. [Fibrinolytic activity of plasma in diabetes mellitus].
    Levantovskaia OM; Sidel'nikova MV
    Lab Delo; 1971; 6():358-9. PubMed ID: 4108752
    [No Abstract]   [Full Text] [Related]  

  • 36. Fibrinolytic agents and their effects on the haemostatic system.
    Kluft C
    Klin Wochenschr; 1988; 66 Suppl 12():50-4. PubMed ID: 2964542
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Blood fibrinolytic activity in patients following myocardial infarct].
    Myśliwiec M; Bielawiec M; Perzanowski A
    Pol Tyg Lek; 1971 Dec; 26(49):1895-7. PubMed ID: 5156516
    [No Abstract]   [Full Text] [Related]  

  • 38. [Status of hemostasis (platelets, coagulation, fibrinolysis) in patients with diabetes mellitus].
    Spesivtseva VG; Golubiatnikova GA; Abylaev Zh; Titova GP; Barkhatova VM
    Ter Arkh; 1979; 51(4):78-84. PubMed ID: 451909
    [No Abstract]   [Full Text] [Related]  

  • 39. Fibrinolytic response of diabetics and non-diabetics to adrenaline.
    Tanser AR
    J Clin Pathol; 1967 May; 20(3):231-3. PubMed ID: 5602554
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Abnormality of clotting and fibrinolysis in diabetes mellitus].
    Terada H
    Nihon Rinsho; 1997 Oct; 55 Suppl():681-7. PubMed ID: 9392181
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.